Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Capital Expenditures (2019 - 2025)

Volitionrx (VNRX) has disclosed Capital Expenditures for 9 consecutive years, with $78591.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Capital Expenditures rose 332.75% year-over-year to $78591.0, compared with a TTM value of $170046.0 through Sep 2025, up 129.83%, and an annual FY2024 reading of $296353.0, changed N/A over the prior year.
  • Capital Expenditures was $78591.0 for Q2 2025 at Volitionrx, down from $91455.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $775027.0 in Q3 2023 and bottomed at -$775027.0 in Q4 2023.
  • Average Capital Expenditures over 5 years is $171687.4, with a median of $136737.0 recorded in 2024.
  • The sharpest move saw Capital Expenditures surged 350.14% in 2022, then plummeted 233.91% in 2023.
  • Year by year, Capital Expenditures stood at $128572.0 in 2021, then soared by 350.14% to $578752.0 in 2022, then tumbled by 233.91% to -$775027.0 in 2023, then surged by 111.8% to $91455.0 in 2024, then dropped by 14.07% to $78591.0 in 2025.
  • Business Quant data shows Capital Expenditures for VNRX at $78591.0 in Q2 2025, $91455.0 in Q4 2024, and $136737.0 in Q3 2024.